Filing Flows › DarioHealth (DRIO) › Q4 2025
DarioHealth (DRIO) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 19, 2026
DarioHealth (DRIO) reported revenue of $5.2M for the fourth quarter 2025 (Q4 2025), -31% from a year earlier and +4% from the quarter before. Operating margin was -163.7%, net loss $9.0M (172.6% of revenue).
DarioHealth, Q4 2025: revenue $5.2M (-31% year over year), operating margin -163.7%, net loss $9.0M, operating cash flow −$5.9M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.2M | +4% | -31% |
| Operating profit | −$8.6M | — | — |
| Net earnings | −$9.0M | — | — |
| Operating cash flow | −$5.9M | — | — |
What changed
Revenue was $5.2M in Q4 2025, down 31% year over year and up 4% from the previous quarter. Services was the largest line at 61% of revenue.
Gross margin was 53.6%, down 1.7 points from Q4 2024. Operating costs exceeded revenue by $8.6M, an operating margin of -163.7%. Operating expenses fell 28% while revenue fell 31%. The quarter ended with a net loss of $9.0M, narrower than the previous quarter's $10.5M loss.
Operating cash flow was −$5.9M. Non-cash charges added back $534K of depreciation and amortization and $2.0M of share-based compensation. Working capital and other items added $572K. Capital expenditures of $26K exceeded it, leaving free cash flow of −$5.9M.
Questions
What was DarioHealth's revenue in the fourth quarter 2025?
DarioHealth (DRIO) reported revenue of $5.2M for the fourth quarter 2025 (Q4 2025), -31% from a year earlier and +4% from the quarter before.
Was DarioHealth profitable in the fourth quarter 2025?
Operating loss was $8.6M (-163.7% of revenue) and net loss $9.0M.
Source: DarioHealth 10-K on SEC EDGAR.